Evolus, Inc. EOLS
7.97
0.11
1.40%
as of 25 Sep
- Market cap
- $519.2M
- P/E
- 0.0×
Follow EOLS
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
512.13% | 587.36% | 245.43% | 138.57% | |
| (26.11%) | (22.53%) | (20.01%) | (14.40%) | ||
ROIC |
(33.33%) | (29.51%) | (19.54%) | (14.47%) | |
Return on Tangible Assets |
(79.88%) | (70.76%) | (56.96%) | (46.48%) | |
Average Days of Receivables |
64.41 | 67.18 | 63.16 | 71.95 | |
Free Cash Flow per Share |
(0.89) | (0.79) | (0.69) | (0.33) | |
Free Cash Flow |
(57.93) | (50.72) | (44.87) | (21.90) | |
Capital Expenditures |
(7.65) | (8.45) | (8.28) | (6.51) | |
Piotroski F-Score |
3.00 | 3.00 | 3.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(31.32%) | (23.90%) | (20.62%) | (8.99%) | |
Accounts Receivable Turnover |
6.01 | 5.81 | 6.06 | 5.75 | |
Accounts Payable Turnover |
5.18 | 6.14 | 5.74 | 3.11 | |
Inventory Turnover |
3.99 | 5.12 | 5.88 | 3.13 | |
Average Days of Payables |
87.86 | 85.21 | 69.58 | 154.21 | |
Days of Inventory on Hand |
125.80 | 98.35 | 88.35 | 141.79 | |
Tax Rate |
0.01 | 0.01 | 0.02 | 0.02 | |
Research and Development Expense of Revenue |
2.98% | 3.22% | 3.18% | 3.05% | |
Selling, General and Administrative Expense of Revenue |
75.70% | 74.29% | 71.61% | 68.41% | |
Share Based Compensation of Revenue |
7.60% | 6.96% | 6.59% | 6.64% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.86 | 0.82 | 0.84 | 0.45 | |
Depreciation/Fixed assets |
1.76 | 1.87 | 2.05 | 2.32 | |
Capex/Depreciation |
(0.85) | (0.84) | (0.76) | (0.56) | |
Revenue per Share |
4.42 | 4.61 | 4.63 | 4.80 | |
Operating CF per Share |
(0.78) | (0.66) | (0.56) | (0.23) | |
Capex per Share |
(0.12) | (0.13) | (0.13) | (0.10) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.02 | |
Net Profit Margin |
(20.49%) | (17.38%) | (14.39%) | (10.85%) |
Columns are period end dates